Bayer announced plans to invest $2.2 billion in a new modular pharmaceutical manufacturing campus in New Albany, Ohio. The company expects about 600 permanent jobs; a drug-substance module is planned to become operational in 2031, followed by a drug-product module in 2034.
Georgia-Pacific began work on an approximately $20 million expansion at its Anchor Packaging facility in Paragould, Arkansas. The project adds two thermoforming lines plus related equipment and infrastructure to increase U.S. production of polypropylene and PET foodservice containers; startup is scheduled for late 2027.
TE Connectivity announced an investment of more than $60 million in a 135,000-square-foot research and manufacturing facility in Henrietta, New York, for high-density fiber array units. The company expects the site to open in spring 2027, ramp manufacturing through 2031 and employ more than 800 people in engineering, manufacturing and management.
Eli Lilly broke ground on a $3.5 billion injectable-medicines and device manufacturing site in Fogelsville, Pennsylvania. The company says the facility will make products including investigational retatrutide, is expected to create 850 permanent jobs and about 2,000 construction jobs, and is targeted to begin operating in 2031.
BASF inaugurated the completed final phase of its methylene diphenyl diisocyanate production expansion at its Geismar, Louisiana, Verbund site. The company says the approximately $1 billion project nearly doubles the site's annual MDI capacity to about 600,000 metric tons and also increases local aniline capacity for North American industrial customers.